Crsp stock forecast 2025.

Find real-time CRSR - Corsair Gaming Inc stock quotes, company profile, news and forecasts from CNN Business.

Crsp stock forecast 2025. Things To Know About Crsp stock forecast 2025.

Stock Price Forecast. The 8 analysts offering 12-month price forecasts for Caribou Biosciences Inc have a median target of 23.00, with a high estimate of 30.00 and a low estimate of 13.00. The ...In January 2025 analysts predict a stock price of $33.02. An increase of 13.4% compared to the previous month's estimate. C3.ai Stock Predictions for Feb 2025. ... Stock Forecast for the Price of an C3.ai Share in Dec 2030. In December 2030, analysts believe the stock price will be $61.87. An increase of 112.45% compared to the previous …Lithium Americas stock prediction for December 2024. In the beginning at 5.79. Maximum 6.00, minimum 5.12. The averaged price 5.62. At the end of the month 5.56 dollars, change for December -4.0%. Lithium Americas stock price forecast for January 2025. In the beginning at 5.56. Maximum 6.43, minimum 5.47.Analyzing the anticipated performance of CRISPR Therapeutics, the ceiling value that the stock is expected to reach in 2025 stands at a promising $75.1. Indicating a bullish trend, an upside potential of 67.9% signals profitable prospects, with an average monthly return of 2.61% , beckoning investors to consider amplifying their portfolios.20 stocks of aerospace and defense companies expected to grow sales most quickly through 2025 Sep. 16, 2023 at 9:07 a.m ...

By 2025, Amazon’s stock price should reach $5,000, and by 2028 it will most likely hit about $10,000, give or take 20%.”. — Jana Kane, LiteForex. AMZN stock was down 7.1% as of Friday ...Find the latest CRISPR Therapeutics AG CRSP analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Date Range …AA Stock 12 Months Forecast. $28.05. (6.49% Upside) Based on 10 Wall Street analysts offering 12 month price targets for Alcoa in the last 3 months. The average price target is $28.05 with a high forecast of $41.00 and a low forecast of $14.00. The average price target represents a 6.49% change from the last price of $26.34.

Forecast for December 2025. It is predicted that the price of one CRISPR Therapeutics share in will be in the range of $52.12 to $60.68. The width of this range will be $8.56 (14.10%). The average price is $54.03, which is $0.17 less than the average price of the previous month.

7 brokers have issued 12-month price objectives for Sangamo Therapeutics' shares. Their SGMO share price targets range from $1.00 to $10.00. On average, they expect the company's stock price to reach $4.68 in the next twelve months. This suggests a possible upside of 1,150.3% from the stock's current price. View analysts price targets …NVIDIA Corporation Common Stock. $408.22 -2.95 0.72%. MULN. Mullen Automotive, Inc. Common Stock. $0.116 +0.0059 5.36%. Find the latest analyst research for CRISPR Therapeutics AG Common Shares ...Lucid Group Inc () Stock Market info Recommendations: Buy or sell Lucid Group stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Lucid Group share forecasts, stock quote and buy / sell signals below.According to present data Lucid Group's LCID shares and potentially its market environment have been in bearish …CRISPR Therapeutics Stock Up 14.6 %. NASDAQ:CRSP opened at $67.89 on Friday. The company’s 50 day moving average price is $46.64 and its 200-day moving average price is $53.09. CRISPR Therapeutics has a 52 week low of $37.55 and a 52 week high of $72.00. The stock has a market cap of $5.39 billion, a price-to-earnings ratio of -15.19 and a ...The Veracyte stock forecast is 49.167390804547 USD for 2024 November 20, Wednesday; and 222.634 USD for 2028 November 20, Monday with technical analysis. Veracyte (VCYT) stock price prediction is 49.167390804547 USD.

Wall Street Stock Market & Finance report, prediction for the future: You'll find the Rambus share forecasts, stock quote and buy / sell signals below. According to present data Rambus's RMBS shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists).

General Motors Company () Stock Market info Recommendations: Buy or sell General Motors stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the General Motors share forecasts, stock quote and buy / sell signals below.According to present data General Motors's GM shares and potentially its market …

Oct 15, 2020 · CRISPR Therapeutics AG (CRSP) stock price prediction is 130.64207402132 USD. The CRISPR Therapeutics AG stock forecast is 130.64207402132 USD for 2024 November 24, Sunday; and 586.145 USD for 2028 November 24, Friday with technical analysis. Find the latest CRISPR Therapeutics AG CRSP analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Date Range investment rating report...Shares of CRISPR Therapeutics ( CRSP -0.74%) sank 50.5% in 2021, according to data from S&P Global Market Intelligence. After surging roughly 151% across 2020's trading, investors reassessed the ...12/02/2023. Microsoft stock price stood at $374.51. According to the latest long-term forecast, Microsoft price will hit $400 by the end of 2023 and then $500 by the end of 2025. Microsoft will rise to $600 within the year of 2026, $700 in 2028, $800 in 2030, $900 in 2033 and $1000 in 2035.Lithium Americas stock prediction for December 2024. In the beginning at 5.79. Maximum 6.00, minimum 5.12. The averaged price 5.62. At the end of the month 5.56 dollars, change for December -4.0%. Lithium Americas stock price forecast for January 2025. In the beginning at 5.56. Maximum 6.43, minimum 5.47.

2025 Forecast: (CRSP) for 2023-2027 Updated: October 27, 2023 An Insight into CRISPR Therapeutics AG Ticker: CRSP Sector: Healthcare Closing price of the last …Wall Street Stock Market & Finance report, prediction for the future: You'll find the Rambus share forecasts, stock quote and buy / sell signals below. According to present data Rambus's RMBS shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists).MERCERWISE 2025 TARGET DATE C- Performance charts including intraday, historical charts and prices and keydata. Indices Commodities Currencies StocksCRISPR Therapeutics Stock Forecast 30 Nov. Presumably, on 11/30/2023, the price of shares will be in the range of $51.94 - $53.92. A $1.98 range width can provide 3.81% volatility. The weighted average price of this range is at $53.49, which is $0.93 higher than the previous day's weighted average price.May 2, 2022 · We asked three Motley Fool contributors to pick beaten-down stocks they think can deliver 5x gains by 2030. Here's why they chose CRISPR Therapeutics ( CRSP -0.74%), Ginkgo Bioworks Holdings ( DNA ... Next reporting date. February 13, 2024. EPS forecast (this quarter) -$0.20. Annual revenue (last year) $185.3M. Annual profit (last year) -$200.2M. Net profit margin.Tesla Stock Forecast 2023, 2024, 2025. Apple stock predictions for January 2025. The forecast for beginning of January 275. Maximum value 293, while minimum 259. Averaged Apple stock price for month 276. Price at the end 276, change for January 0.36%. Apple stock price predictions for February 2025.

Analyzing the anticipated performance of CRISPR Therapeutics, the ceiling value that the stock is expected to reach in 2025 stands at a promising $75.1. Indicating a bullish trend, an upside potential of 67.9% signals profitable prospects, with an average monthly return of 2.61% , beckoning investors to consider amplifying their portfolios.

CRSP stock has fallen 16% over the last month (twenty-one trading days), after a rise in bond yields, along with rising concerns over the spread of a newer Covid-19 variant - Omicron - led to a ...According to 42 stock analysts, the average 12-month stock price forecast for Amazon stock is $170.76, which predicts an increase of 16.14%. The lowest target is $116 and the highest is $230. On average, analysts rate Amazon stock as a strong buy.Ford stock (F) has risen by more than 40 percent year-to-date, in part due to its strong EV potential. What's Ford's stock forecast for 2025? Growth stocks, including pure-play EV (electric ...Find the latest CRISPR Therapeutics AG CRSP analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Date Range …Jun 9, 2021 · For Vaxart stock forecast for 2033 (10 year), 10 predictions are offered for each month of 2033 with average Vaxart stock forecast of $16.43, a high forecast of $18.46, and a low forecast of $12.03. The average Vaxart stock forecast 2033 represents a 2389.86% increase from the last price of $0.660000026226044. Please, see more forecasts below. Nov 1, 2023 · Forecast for December 2025. It is predicted that the price of one CRISPR Therapeutics share in will be in the range of $52.12 to $60.68. The width of this range will be $8.56 (14.10%). The average price is $54.03, which is $0.17 less than the average price of the previous month. The Upstart Holdings stock prediction for 2025 is currently $ 64.08, assuming that Upstart Holdings shares will continue growing at the average yearly rate as they did in the last 10 years. This would represent a 141.45% increase in the UPST stock price. Nov 28, 2023 · CRISPR Therapeutics (CRSP) stock forecast for 2025 Last update: November 21, 2023 (07:48) Sector: Healthcare The share price of CRISPR Therapeutics AG (CRSP) now CRISPR Therapeutics AG 69.97 D 0.74% (0.52) What analysts predict: $87.78 52-week High/Low: $76.19 / $37.55 50/200 Day Moving Average: $46.64 / $51.55 The average twelve-month price prediction for CRISPR Therapeutics is $69.88 with a high price target of $110.00 and a low price target of $42.00. Learn more on CRSP's analyst rating history. Do Wall Street analysts like CRISPR Therapeutics more than its competitors?CRISPR Therapeutics Stock Up 14.6 %. NASDAQ:CRSP opened at $67.89 on Friday. The company’s 50 day moving average price is $46.64 and its 200-day moving average price is $53.09. CRISPR Therapeutics has a 52 week low of $37.55 and a 52 week high of $72.00. The stock has a market cap of $5.39 billion, a price-to-earnings ratio of -15.19 and a ...

Nov 20, 2023 · The mean of analysts' price targets for CRISPR Therapeutics AG (CRSP) points to a 33.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong ...

22 thg 12, 2022 ... The news had a broad impact on gene-editing stocks including CRSP stock, which fell almost 3%. ... CRISPR Therapeutics Shows Rising Price ...

CRSP - CRISPR Therapeutics Stock Prediction 2025 - 2030 + Portfolio 7 years of reliable CRISPR Therapeutics stock forecast. The Wall Street analysts predict Outperform for CRSP. See at a glance whether NasdaqGM:CRSP will rise in the future. $41.47 Forecast 2023 $49.60 Forecast 2025 $77.58 Forecast 2030 Underperform TopGraphs Quality RankingForecast target price for 10-29-2023: $41.07. Positive dynamics for CRISPR Therapeutics shares will prevail with possible volatility of 2.788%. Pessimistic ...Amazon Stock Forecast 12-07-2023. Forecast target price for 12-07-2023: $ 150.20. Positive dynamics for Amazon shares will prevail with possible volatility of 1.272%. Pessimistic target level: 149.24. Optimistic target level: 151.16.After this upgrade, CRISPR Therapeutics' 28 analysts are now forecasting revenues of US$239m in 2023. This would be a sizeable 40% improvement in sales compared to the last 12 months. Losses are ...7 brokers have issued 12-month price objectives for Sangamo Therapeutics' shares. Their SGMO share price targets range from $1.00 to $10.00. On average, they expect the company's stock price to reach $4.68 in the next twelve months. This suggests a possible upside of 1,150.3% from the stock's current price. View analysts price targets …Oct 26, 2023 · Price Prediction forecast forCRISPR Therapeutics to October 27, and an in-depth analysis for the week of 22 October to 28 October. Monthly forecasts CRSP for 2023 with target levels, support & resistance insights to make informed investment decisions. CRSP: Keep it Crisp for 2025. dsypher Aug 15. A little idea for CRSP ... stock drop below $ 57.80 then Sell ITM Put for $ 75 and collect high premium. 3.Find real-time NCLH - Norwegian Cruise Line Holdings Ltd stock quotes, company profile, news and forecasts from CNN Business.Wall Street Stock Market & Finance report, prediction for the future: You'll find the Bionano Genomics share forecasts, stock quote and buy / sell signals below. According to present data Bionano Genomics's BNGO shares and potentially its market environment have been in bearish cycle last 12 months (if exists).According to 42 stock analysts, the average 12-month stock price forecast for Amazon stock is $170.76, which predicts an increase of 16.14%. The lowest target is $116 and the highest is $230. On average, analysts rate Amazon stock as a strong buy.Palantir Technologies Inc - Class A (PLTR) stock price prediction is 15.953138725275 USD. The Palantir Technologies Inc - Class A stock forecast is 15.953138725275 USD for 2024 December 01, Sunday with technical analysis.

15 brokers have issued 12-month price objectives for CRISPR Therapeutics' shares. Their CRSP share price targets range from $42.00 to $110.00. On average, they anticipate the company's share price to reach $69.88 in the next year. This suggests a possible upside of 2.9% from the stock's current price.Be the first to know when Wall Street analysts revise their ASML stock forecasts and price targets. Get Free ASML Updates. ASML stock forecasts by analyst. All Analysts Top Analysts. ... In 2025, ASML is forecast to generate $13,732,219,460,400 in revenue, with the lowest revenue forecast at $12,431,837,334,000 and the highest revenue forecast ...December 2025. Festive spending and end-of-year portfolio adjustments might lead VOO to end on a high note. Predicted Price Range: $450-$470. In the realm of investments, understanding potential trajectories like this can be empowering. Yet, always remember that these are speculative figures.Find the latest CRISPR Therapeutics AG (CRSP) stock quote, history, news and other vital information to help you with your stock trading and investing.Instagram:https://instagram. stock trade signalsstock exchange simulator appbuy nike stockgrocery outlet instacart Price Prediction forecast forCRISPR Therapeutics to October 27, and an in-depth analysis for the week of 22 October to 28 October. Monthly forecasts CRSP for 2023 with target levels, support & resistance insights to make informed investment decisions.Traders Union experts conducted a comprehensive analysis and predicted that by the end of 2024 Google price will hit $179.92. Google will grow to $200.9 in 2025, $279.67 in 2028 and $348.68 in 2030. Traders Union analysts have prepared a selection of analytical forecasts from top portals for 2024, 2025, 2030. quote gldcan you get supplemental dental insurance CRISPR Therapeutics (CRSP) stock forecast for 2025. Forecast tables and graphs. All stock predictions Overall outlook for CRISPR Therapeutics stock 2023 …Bionano Genomics Inc () Stock Market info Recommendations: Buy or sell Bionano Genomics stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Bionano Genomics share forecasts, stock quote and buy / sell signals below.According to present data Bionano Genomics's BNGO shares and potentially its … mckesson corp stock CRSP Stock 12 Months Forecast. Based on 16 Wall Street analysts offering 12 month price targets for Crispr Therapeutics AG in the last 3 months. The average price target is $85.25 with a high forecast of $220.00 and a low forecast of $42.00. The average price target represents a 21.84% change from the last price of $69.97.Stock Price Forecast The 19 analysts offering 12-month price forecasts for MercadoLibre Inc have a median target of 1,700.00, with a high estimate of 2,120.00 and a low estimate of 1,500.00.Shares of CRISPR Therapeutics ( CRSP -7.40%) sank 50.5% in 2021, according to data from S&P Global Market Intelligence. After surging roughly 151% across 2020's trading, investors reassessed the ...